NeXendia

Zürich, Switzerland

NeXendia is a functional liquid biopsy company. We decode cell-free RNA to make genetic medicines measurable inside patients, capturing functional cfRNA-protein complexes that static, mutation-based liquid biopsy misses. From a simple blood draw we read, in real time and non-invasively, whether a drug reaches its target and how the body responds. Our first application monitors RNA therapeutics such as siRNA, a dynamic efficacy and safety signal for pharma and biotech.